See today's BioWorld Science
To read the full story, subscribe or sign in.
Neurology/Psychiatric

Juvena’s JUV-161 awarded US orphan drug designation for myotonic dystrophy type 1

Jan. 24, 2024
The FDA has awarded orphan drug designation to Juvena Therapeutics Inc.’s JUV-161, an...
BioWorld Science Regulatory Neurology/psychiatric FDA IND